Predictive biomarkers for combined chemotherapy with 5‑fluorouracil and cisplatin in oro‑ and hypopharyngeal cancers-Reference-Cited by-同舟云学术

Predictive biomarkers for combined chemotherapy with 5‑fluorouracil and cisplatin in oro‑ and hypopharyngeal cancers

Published:2017-11-29 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Hasegawa Yasuhisa¹,Goto Mitsuo²,Hanai Nobuhiro¹,Ozawa Taijiro³,Hirakawa Hitoshi⁴

Affiliation:

1. Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Chikusaku, Nagoya 464‑8681, Japan

2. Department of Maxillofacial Surgery, Aichi Gakuin University, Chikusaku, Nagoya 464‑8650, Japan

3. Department of Otorhinolaryngology, Toyohashi Municipal Hospital, Aotakecho, Toyohashi 441‑8570, Japan

4. Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of The Ryukyus, Nishiharacho, Okinawa 903‑0215, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas;Medicine;2023-09-08

2. The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections;Cancers;2023-05-11

3. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival;International Journal of Molecular Sciences;2023-02-01

4. Research Progress on the Treatment of Hypopharyngeal Cancer;Advances in Clinical Medicine;2023

5. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma;Frontiers in Oncology;2022-10-21